Ishii Yasushi, Fukui-Miyazaki Aya, Iwasaki Sari, Tsuji Takahiro, Hotta Kiyohiko, Sasaki Hajime, Nakagawa Shimpei, Yoshida Takuma, Murata Eri, Taniguchi Koji, Shinohara Nobuo, Ishizu Akihiro, Kasahara Masanori, Tomaru Utano
Department of Pathology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan.
Department of Medical Laboratory Science, Faculty of Health Sciences, Hokkaido University, Sapporo, Hokkaido, Japan.
Exp Mol Pathol. 2024 Dec;140:104939. doi: 10.1016/j.yexmp.2024.104939. Epub 2024 Oct 18.
Oxidative stress caused by reactive oxygen species (ROS) is involved in the pathogenesis of renal ischemia-reperfusion injury (I/R injury), a major cause of acute kidney injury and delayed graft function (DGF). DGF is an early transplant complication that worsens graft prognosis and patient survival, but the underlying molecular changes are unclear. The proteasome is a multicatalytic enzyme complex that degrades both normal and damaged proteins, and recent studies have revealed that the immunoproteasome, a specific proteasome isoform whose proteolytic activity enhances the generation of antigenic peptides, plays critical roles in the cellular response against oxidative stress. In this study, we demonstrate the impact of the immunoproteasome in human DGF and in a mouse model of I/R injury. In patients with DGF, the expression of β5i, a specific immunoproteasome subunit, was decreased in vascular endothelial cells. In a mouse model, β5i knockout (KO) exacerbated renal I/R injury. KO mice showed greater inflammation, oxidative stress, and endothelial damage compared with wild-type mice. Impaired immunoproteasomal activity also caused increased cell death, ROS production, and expression of inflammatory factors in mouse renal vascular endothelial cells under conditions of hypoxia and reoxygenation. In conclusion, reduced expression of the immunoproteasomal catalytic subunit β5i exacerbates renal I/R injury in vivo, potentially increasing the risk of DGF. Further research targeting β5i expression in DGF could lead to the development of novel therapeutic strategies and biomarkers.
由活性氧(ROS)引起的氧化应激参与了肾缺血再灌注损伤(I/R损伤)的发病机制,肾缺血再灌注损伤是急性肾损伤和移植肾功能延迟(DGF)的主要原因。DGF是一种早期移植并发症,会恶化移植预后和患者生存率,但其潜在的分子变化尚不清楚。蛋白酶体是一种多催化酶复合物,可降解正常和受损蛋白质,最近的研究表明,免疫蛋白酶体是一种特定的蛋白酶体异构体,其蛋白水解活性增强抗原肽的产生,在细胞对氧化应激的反应中起关键作用。在本研究中,我们证明了免疫蛋白酶体在人类DGF和I/R损伤小鼠模型中的影响。在DGF患者中,血管内皮细胞中特异性免疫蛋白酶体亚基β5i的表达降低。在小鼠模型中,β5i基因敲除(KO)加剧了肾I/R损伤。与野生型小鼠相比,KO小鼠表现出更严重的炎症、氧化应激和内皮损伤。在缺氧和复氧条件下,免疫蛋白酶体活性受损还导致小鼠肾血管内皮细胞中细胞死亡增加、ROS产生和炎症因子表达增加。总之,免疫蛋白酶体催化亚基β5i表达降低会加剧体内肾I/R损伤,可能增加DGF的风险。针对DGF中β5i表达的进一步研究可能会导致新治疗策略和生物标志物的开发。